Evidence map›Paper›PMID 38887741›Full record

ArticlePulmonary circulation2024

Association of mildly elevated pulmonary vascular resistance with major cardiovascular events in pulmonary hypertension and chronic kidney disease: A retrospective cohort analysis.

Jose M Martinez Manzano, Alexander Prendergast, Tara John, Raul Leguizamon, Ian McLaren, Rasha Khan, Andrew Geller, Phuuwadith Wattanachayakul, John Malin, Simone A Jarrett and 3 more

Abstract read
In one paragraph

Article in Pulmonary circulation, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Jose M Martinez ManzanoDepartment of Medicine Jefferson Einstein Hospital Philadelphia Pennsylvania USA.ORCID https://orcid.org/0000-0002-5688-9692
Alexander PrendergastDepartment of Medicine Jefferson Einstein Hospital Philadelphia Pennsylvania USA.
Tara JohnDepartment of Medicine Jefferson Einstein Hospital Philadelphia Pennsylvania USA.
Raul LeguizamonDepartment of Medicine Jefferson Einstein Hospital Philadelphia Pennsylvania USA.
Ian McLarenDepartment of Medicine Jefferson Einstein Hospital Philadelphia Pennsylvania USA.
Rasha KhanDepartment of Medicine Jefferson Einstein Hospital Philadelphia Pennsylvania USA.
Andrew GellerDepartment of Medicine Jefferson Einstein Hospital Philadelphia Pennsylvania USA.
Phuuwadith WattanachayakulDepartment of Medicine Jefferson Einstein Hospital Philadelphia Pennsylvania USA.
John MalinDepartment of Medicine Jefferson Einstein Hospital Philadelphia Pennsylvania USA.
Simone A JarrettDepartment of Medicine Jefferson Einstein Hospital Philadelphia Pennsylvania USA.
Kevin Bryan LoDepartment of Medicine Jefferson Einstein Hospital Philadelphia Pennsylvania USA.
Sadia BenzaquenDepartment of Pulmonary and Critical Care Jefferson Einstein Hospital Philadelphia Pennsylvania USA.
Christian WitzkeDepartment of Cardiology Jefferson Einstein Hospital Philadelphia Pennsylvania USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Pulmonary hypertension (PH) is associated with adverse outcomes in chronic kidney disease (CKD) patients. Our study suggests mildly elevated pulmonary vascular resistance ( > 2 to ≤ 3) is independently associated with major adverse cardiovascular events at 1-year follow-up. Early diagnosis of precapillary PH in CKD patients can potentially improve clinical outcomes.

Indexed as

hypertensive vascular renal diseasepulmonary hypertensionrenal hemodynamics

Identifiers

PMID38887741
PMCPMC11181768

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.